CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- 8-K Event Other events
- 4 Open-market sale CEO sold 7,265 shares at $5.66 ($41,105)
- 4 Open-market sale Chief Scientific Officer sold 7,265 shares at $5.66 ($41,105)
- 8-K/A Event Shareholder vote results
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 500 shares at $5.49 ($2,745)
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B3 Offering Prospectus
- S-1/A Offering Registration Statement
Page 28 of 33 · 643 filings